What is the share price of Eiko Lifesciences Ltd (EIKO) today?
The share price of EIKO as on 12th May 2025 is ₹49.59. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Eiko Lifesciences Ltd (EIKO) share?
The past returns of Eiko Lifesciences Ltd (EIKO) share are- Past 1 week: -3.38%
- Past 1 month: -4.28%
- Past 3 months: 0.73%
- Past 6 months: -20.72%
- Past 1 year: -7.17%
- Past 3 years: 33.25%
- Past 5 years: 540.30%
What are the peers or stocks similar to Eiko Lifesciences Ltd (EIKO)?
The peers or stocks similar to Eiko Lifesciences Ltd (EIKO) include:What is the market cap of Eiko Lifesciences Ltd (EIKO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Eiko Lifesciences Ltd (EIKO) is ₹67.00 Cr as of 12th May 2025.What is the 52 week high and low of Eiko Lifesciences Ltd (EIKO) share?
The 52-week high of Eiko Lifesciences Ltd (EIKO) is ₹74.88 and the 52-week low is ₹42.What is the PE and PB ratio of Eiko Lifesciences Ltd (EIKO) stock?
The P/E (price-to-earnings) ratio of Eiko Lifesciences Ltd (EIKO) is 88.16. The P/B (price-to-book) ratio is 1.32.Which sector does Eiko Lifesciences Ltd (EIKO) belong to?
Eiko Lifesciences Ltd (EIKO) belongs to the Materials sector & Specialty Chemicals sub-sector.How to buy Eiko Lifesciences Ltd (EIKO) shares?
You can directly buy Eiko Lifesciences Ltd (EIKO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Eiko Lifesciences Ltd
EIKO Share Price
EIKO Share Price Chart
EIKO Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
EIKO Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
68.37 | 1.32 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
27.09 | 3.28 | 1.75% |
EIKO Analyst Ratings & Forecast
Detailed Forecast Price Upside
Earnings Growth
Rev. Growth
EIKO Company Profile
Eiko LifeSciences Ltd specializes in manufacturing specialty and fine chemicals, including pharma intermediates and cosmetic ingredients, catering to diverse industrial needs.
EIKO Similar Stocks (Peers)
Compare with peersEIKO Forecasts
Price
Revenue
Earnings
EIKO Share Price Forecast
EIKO Company Revenue Forecast
EIKO Stock EPS (Earnings Per Share) Forecast
EIKO
Income
Balance Sheet
Cash Flow
EIKO Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 0.58 | 0.40 | 0.51 | 0.39 | 0.43 | 12.45 | 26.08 | 19.17 | 28.11 | 27.73 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.67 | 25.05 | 13.66 | 27.20 | 25.83 | ||||||||||
Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.10 | 0.04 | 0.07 | |||||||||||
Employee Cost | 0.10 | 0.06 | 0.07 | 0.02 | 0.07 | 0.12 | 0.23 | 0.23 | 0.16 | |||||||||||
Selling & Administrative Expenses | 0.36 | 0.08 | 0.11 | 0.17 | 0.10 | 0.20 | 0.45 | 0.42 | 0.47 | |||||||||||
Operating & Other expenses | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.47 | -1.73 | 3.01 | -1.59 | |||||||||||
EBITDA | 0.12 | 0.26 | 0.33 | 0.20 | 0.26 | 0.97 | 1.98 | 1.81 | 1.80 | 1.90 | ||||||||||
Depreciation/Amortization | 0.00 | 0.02 | 0.06 | 0.06 | 0.06 | 0.06 | 0.56 | 0.63 | 0.66 | 0.53 | ||||||||||
PBIT | 0.12 | 0.24 | 0.27 | 0.14 | 0.20 | 0.91 | 1.42 | 1.18 | 1.14 | 1.37 | ||||||||||
Interest & Other Items | 0.00 | 0.02 | 0.05 | 0.03 | 0.07 | 0.09 | 0.48 | 0.16 | 0.15 | 0.20 | ||||||||||
PBT | 0.12 | 0.22 | 0.22 | 0.11 | 0.13 | 0.82 | 0.94 | 1.02 | 0.99 | 1.17 | ||||||||||
Taxes & Other Items | 0.03 | 0.06 | 0.03 | 0.03 | 0.00 | 0.22 | 0.23 | 0.26 | 0.23 | 0.19 | ||||||||||
Net Income | 0.09 | 0.16 | 0.19 | 0.08 | 0.13 | 0.60 | 0.71 | 0.76 | 0.76 | 0.98 | ||||||||||
EPS | 0.26 | 0.46 | 0.48 | 0.18 | 0.29 | 1.36 | 1.01 | 0.79 | 0.65 | 0.71 | ||||||||||
DPS | 0.00 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EIKO Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFEIKO Past Performance & Peer Comparison
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Eiko Lifesciences Ltd | 88.16 | 1.32 | — |
Gujarat Fluorochemicals Ltd | 95.65 | 7.01 | 0.08% |
Navin Fluorine International Ltd | 78.96 | 9.56 | 0.26% |
Vinati Organics Ltd | 52.05 | 6.83 | 0.43% |
EIKO Stock Price Comparison
Compare EIKO with any stock or ETFEIKO Shareholdings
EIKO Promoter Holdings Trend
In last 6 months, promoter holding in the company has increased by 11.83%
Pledged promoter holdings is insignificant
EIKO Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
EIKO Shareholding Pattern
EIKO Shareholding History
smallcases containing EIKO stock
Looks like this stock is not in any smallcase yet.
EIKO Events
EIKO Dividend Trend
EIKO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
EIKO Upcoming Dividends
No upcoming dividends are available
EIKO Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2017
Dividend/Share
₹0.25
Ex DateEx Date
Sep 20, 2017
EIKO Stock News & Opinions
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live
Net profit of Eiko Lifesciences rose 16.67% to Rs 0.28 crore in the quarter ended December 2024 as against Rs 0.24 crore during the previous quarter ended December 2023. Sales rose 4.54% to Rs 6.91 crore in the quarter ended December 2024 as against Rs 6.61 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales6.916.61 5 OPM %6.517.11 - PBDT0.530.45 18 PBT0.380.29 31 NP0.280.24 17 Powered by Capital Market - Live
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 25 November 2024Powered by Capital Market - Live
Net profit of Eiko Lifesciences rose 75.00% to Rs 0.21 crore in the quarter ended September 2024 as against Rs 0.12 crore during the previous quarter ended September 2023. Sales rose 20.75% to Rs 7.74 crore in the quarter ended September 2024 as against Rs 6.41 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales7.746.41 21 OPM %4.655.46 - PBDT0.450.32 41 PBT0.290.16 81 NP0.210.12 75 Powered by Capital Market - Live
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 19 October 2024.Powered by Capital Market - Live
Eiko Lifesciences announced that the 47th Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
Net profit of Eiko Lifesciences rose 337.50% to Rs 0.35 crore in the quarter ended June 2024 as against Rs 0.08 crore during the previous quarter ended June 2023. Sales rose 65.13% to Rs 10.75 crore in the quarter ended June 2024 as against Rs 6.51 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales10.756.51 65 OPM %3.814.15 - PBDT0.640.27 137 PBT0.470.11 327 NP0.350.08 338 Powered by Capital Market - Live
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 135.27%, vs industry avg of 6.07%
Over the last 5 years, market share increased from 0% to 0.03%
Over the last 5 years, net income has grown at a yearly rate of 56.87%, vs industry avg of -1.25%